InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
InspireMD (Nasdaq: NSPR) will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 PM ET. The company, developer of the CGuard Prime carotid stent system, said a live audio webcast and a replay will be available on its Investor Calendar page. Investors can access the event via the provided webcast link and listen live or via the replay on the company website.
Positive
- None.
Negative
- None.
News Market Reaction – NSPR
In the Nov 20 session, NSPR declined 11.46%, reflecting a significant negative market reaction. Argus tracked a trough of -17.6% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion at the upcoming Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3rd at 12:30 pm Eastern Time (ET).
A live audio webcast and replay of the discussion may be accessed on the “Investor Calendar” section of the company’s website at: https://event.webcasts.com/starthere.jsp?ei=1744172&tp_key=a1a6262ba9
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com